In this population‐based cohort study of almost 2.5 million children, we found an increased ALL risk in children delivered by planned CS, stemming from B‐cell precursor ALL, and specifically the HeH/ ETV6::RUNX1 subtypes. This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.